Interestingly, the lower expression level of RBPMS was also observed in CIS and CIS-derived tumors compared to PUC and PUC-derived tumors (Supplementary Fig. 6c), which indicated that the difference of RBPMS has occurred in the early period of disease. The gene discussed is RBPMS; the disease is in situ carcinoma.